Ledger.Open graph →
SEC Form D · filed January 17, 2020

INNOVATE BIOPHARMACEUTICALS, INC

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Jay P. Madan · Raleigh, NCExec · DirectorLorin K. Johnson · Raleigh, NCDirectorRoy K. Proujansky · Raleigh, NCDirectorSaira K. Ramasastry · Raleigh, NCDirectorAnthony Maida · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorEdward J. Sitar · Raleigh, NCExecJeffrey Myers · New York, NYDirectorArnar Agnarsson · Bozeman, MTDirectorJohn Bykowski · Hayward, CAExec · DirectorScott Zeilinger · New York, NYExec · DirectorRyan Belanger-Saleh · New York, NYDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorKevin Cavenaugh · Portland, ORExec · DirectorLorne Thomas · Odessa, FLExec · DirectorWilliam P. Corry · Sewickley, PADirectorChristopher Long · Mission Woods, KSDirectorShinji Kim · SAN FRANCISCO, CADirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirectorEdward J. Sitar · Raleigh, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗